135 related articles for article (PubMed ID: 35681118)
1. The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer.
Zhang W; Cao H; Yang J; Zhao J; Liang Z; Kang X; Wang R
BMC Cancer; 2022 Jun; 22(1):636. PubMed ID: 35681118
[TBL] [Abstract][Full Text] [Related]
2. SOX14 hypermethylation as a tumour biomarker in cervical cancer.
Zhao J; Cao H; Zhang W; Fan Y; Shi S; Wang R
BMC Cancer; 2021 Jun; 21(1):675. PubMed ID: 34098886
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation of EphA7 in human prostate cancer and its relation to clinicopathologic features.
Guan M; Xu C; Zhang F; Ye C
Int J Cancer; 2009 Jan; 124(1):88-94. PubMed ID: 18821581
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of EphA7 by hypermethylation in colorectal cancer.
Wang J; Kataoka H; Suzuki M; Sato N; Nakamura R; Tao H; Maruyama K; Isogaki J; Kanaoka S; Ihara M; Tanaka M; Kanamori M; Nakamura T; Shinmura K; Sugimura H
Oncogene; 2005 Aug; 24(36):5637-47. PubMed ID: 16007213
[TBL] [Abstract][Full Text] [Related]
5. Loss of EphA7 Expression in Basal Cell Carcinoma by Hypermethylation of CpG Islands in the Promoter Region.
Liu J; Yu N; Feng X; He Y; Lv K; Zhu H; Wang J
Anal Cell Pathol (Amst); 2022; 2022():4220786. PubMed ID: 35103233
[TBL] [Abstract][Full Text] [Related]
6. Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis.
Guenin S; Mouallif M; Deplus R; Lampe X; Krusy N; Calonne E; Delbecque K; Kridelka F; Fuks F; Ennaji MM; Delvenne P
PLoS One; 2012; 7(8):e42704. PubMed ID: 22880087
[TBL] [Abstract][Full Text] [Related]
7. Secreted form of EphA7 in lung cancer.
Tsuboi M; Mori H; Bunai T; Kageyama S; Suzuki M; Okudela K; Takamochi K; Ogawa H; Niwa H; Shinmura K; Sugimura H
Int J Oncol; 2010 Mar; 36(3):635-40. PubMed ID: 20126984
[TBL] [Abstract][Full Text] [Related]
8. Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.
Yin FF; Wang N; Bi XN; Yu X; Xu XH; Wang YL; Zhao CQ; Luo B; Wang YK
Virol J; 2016 Apr; 13():60. PubMed ID: 27044426
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of methylation-silenced PAX1 inhibits cervical cancer proliferation and migration via the WNT/TIMELESS pathway.
Zhang W; Wang H; Chen S; Fan X; Liu Y; Shi S; Wang R
Mol Carcinog; 2024 May; ():. PubMed ID: 38712797
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer.
Zhang J; Lin Z; Gao Y; Yao T
J Exp Clin Cancer Res; 2017 Jan; 36(1):5. PubMed ID: 28057015
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of EphA7 receptor tyrosine kinase in gastric carcinoma.
Wang J; Li G; Ma H; Bao Y; Wang X; Zhou H; Sheng Z; Sugimura H; Jin J; Zhou X
Hum Pathol; 2007 Nov; 38(11):1649-56. PubMed ID: 17669470
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis.
Yang WT; Zheng PS
PLoS One; 2014; 9(2):e88827. PubMed ID: 24551169
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Hypermethylation of SALL3 with HPV Involvement Contributes to the Carcinogenesis of Cervical Cancer.
Wei X; Zhang S; Cao D; Zhao M; Zhang Q; Zhao J; Yang T; Pei M; Wang L; Li Y; Yang X
PLoS One; 2015; 10(12):e0145700. PubMed ID: 26697877
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of ZAR1 and SFRP4 methylation status as potentials biomarkers for diagnosis in cervical cancer: exploratory study phase I.
Brebi P; Hoffstetter R; Andana A; Ili CG; Saavedra K; Viscarra T; Retamal J; Sanchez R; Roa JC
Biomarkers; 2014 May; 19(3):181-8. PubMed ID: 24787227
[TBL] [Abstract][Full Text] [Related]
15. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
[TBL] [Abstract][Full Text] [Related]
16. Aberrant Methylation of the SOX21-AS1 Promoter Region Promotes Gene Expression and Its Clinical Value in Cervical Cancer.
Du P; Zhi Y; Wang R; Li Y; Li H; Zhang X; Cheng G; Li X
Reprod Sci; 2021 Feb; 28(2):532-540. PubMed ID: 33095426
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide methylation profiling reveals Zinc finger protein 516 (ZNF516) and FK-506-binding protein 6 (FKBP6) promoters frequently methylated in cervical neoplasia, associated with HPV status and ethnicity in a Chilean population.
Brebi P; Maldonado L; Noordhuis MG; Ili C; Leal P; Garcia P; Brait M; Ribas J; Michailidi C; Perez J; Soudry E; Tapia O; Guzman P; Muñoz S; Van Neste L; Van Criekinge W; Irizarry R; Sidransky D; Roa JC; Guerrero-Preston R
Epigenetics; 2014 Feb; 9(2):308-17. PubMed ID: 24241165
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between DNA Methylation of ZNF772 Promoter Region and Cervical Cancer].
Li M; Li O; Sun J; Zheng X; Ma D
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Apr; 42(2):164-171. PubMed ID: 32385021
[No Abstract] [Full Text] [Related]
19. Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells.
Masuda K; Banno K; Yanokura M; Tsuji K; Kobayashi Y; Kisu I; Ueki A; Yamagami W; Nomura H; Tominaga E; Susumu N; Aoki D
Oncol Rep; 2012 Oct; 28(4):1146-52. PubMed ID: 22797812
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation regulated microRNAs in human cervical cancer.
Varghese VK; Shukla V; Kabekkodu SP; Pandey D; Satyamoorthy K
Mol Carcinog; 2018 Mar; 57(3):370-382. PubMed ID: 29077234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
